CorMedix CRMD Available-for-Sale Debt Securities - Amortized Cost
Available-for-Sale Debt Securities - Amortized Cost at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's available-for-sale debt securities - amortized cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's available-for-sale debt securities - amortized cost?
- CorMedix (CRMD) reported available-for-sale debt securities - amortized cost of $8.5M in Q4 2025.
- How has CorMedix's available-for-sale debt securities - amortized cost changed year-over-year?
- CorMedix's available-for-sale debt securities - amortized cost decreased by 75.1% year-over-year, from $34.16M to $8.5M.
- What is the long-term trend for CorMedix's available-for-sale debt securities - amortized cost?
- Over 3 years (2022 to 2025), CorMedix's available-for-sale debt securities - amortized cost has grown at a -28.2% compound annual growth rate (CAGR), from $22.96M to $8.5M.
- What does available-for-sale debt securities - amortized cost mean?
- This is the cost basis of debt securities classified as available-for-sale, adjusted for amortization of premiums or discounts. It represents the value of the investment portfolio before accounting for current market price fluctuations. This provides a baseline for evaluating the performance of the company's liquid investment strategy.